Stock Ticker

  • Loading stock data...

Three Small-Cap Plays that Offer Some Bang for the Buck (CLVS, QBIO, BPMC)

The carnage in the biotech space in Q4 of last year was devastating to a lot of portfolios, and many of the stocks in the space became victims of aggressive tax-loss selling before year end to add insult to injury. But, rejoice, dear investor! That just means we have some great values lying around on […]

Clovis Oncology Inc (NASDAQ:CLVS) Going Strong With The Clinical Developmental Programs

Boston, MA 08/11/2014 (wallstreetpr) – Clovis Oncology Inc (NASDAQ:CLVS) posted second quarter financial results and gave the necessary information on its clinical developmental programs for the year. It said that the CO-1686 NDA submission is expected by mid-2015. President and CEO, Patrick J. Mahaffy said that the company is going through an exciting time. It […]

Before You Trade: Double Eagle Petroleum Co (NASDAQ:DBLE), Clovis Oncology Inc (NASDAQ:CLVS), Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

Boston, MA 03/27/2014 (wallstreetpr) – The anticipated change of guard and name at Double Eagle Petroleum Co (NASDAQ:DBLE) seem to be taken positively among investors. Moreover, promises by the company to expand its operations, attract more industry experts and boost income are all coming as good news to the shareholders. The company, in a statement, […]

Clovis Oncology Inc (NASDAQ:CLVS) announced its Preliminary results of ovarian cancer drug

Boston, MA 06/04/2013 (wallstreetpr) – The share prices of Clovis Oncology Inc (NASDAQ:CLVS) had surged by more than 100 percent owing to the successful preliminary testing results of its drug for treating ovarian cancer. The shares of the bio pharmaceutical company had increased by 103.91 percent to close at $74.59 per share for the trading session […]

Sign Up To Get Our Latest Stocks Alerts